4len: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 20: | Line 20: | ||
==See Also== | ==See Also== | ||
*[[Beta-lactamase|Beta-lactamase]] | *[[Beta-lactamase 3D structures|Beta-lactamase 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 12:05, 17 July 2019
CTX-M-9 in complex with the broad spectrum inhibitor 3-(2- carboxyvinyl)benzo(b)thiophene-2-boronic acid
| ||||||||||||
Proteopedia Page Contributors and Editors (what is this?)
Categories:
- Bacillus coli migula 1895
- Beta-lactamase
- Large Structures
- Tondi, D
- Bacterial resistance
- Beta lactamase
- Binding site
- Boronic acid
- Broad spectrum
- Double perturbation cycle analysis
- Drug discovery
- Enzyme inhibitor
- Hydrolase-hydrolase inhibitor complex
- Molecular
- Structure activity relationship
- Structure base drug design
- Thermodynamic